Financhill
Buy
65

KLAC Quote, Financials, Valuation and Earnings

Last price:
$1,215.40
Seasonality move :
9.57%
Day range:
$1,214.09 - $1,250.93
52-week range:
$551.33 - $1,286.81
Dividend yield:
0.61%
P/E ratio:
38.15x
P/S ratio:
12.92x
P/B ratio:
32.03x
Volume:
608K
Avg. volume:
880.3K
1-year change:
92.83%
Market cap:
$159.7B
Revenue:
$12.1B
EPS (TTM):
$31.85

Analysts' Opinion

  • Consensus Rating
    KLA Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 10 Buy ratings, 14 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $1,320.96, KLA Corp. has an estimated upside of 8.71% from its current price of $1,215.08.
  • Price Target Downside
    According to analysts, the lowest downside price target is $1,000.00 representing 100% downside risk from its current price of $1,215.08.

Fair Value

  • According to the consensus of 24 analysts, KLA Corp. has 8.71% upside to fair value with a price target of $1,320.96 per share.

KLAC vs. S&P 500

  • Over the past 5 trading days, KLA Corp. has underperformed the S&P 500 by -3.05% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • KLA Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • KLA Corp. has grown year-over-year revenues for 6 quarters straight. In the most recent quarter KLA Corp. reported revenues of $3.2B.

Earnings Growth

  • KLA Corp. has grown year-over-year earnings for 6 quarters straight. In the most recent quarter KLA Corp. reported earnings per share of $8.47.
Enterprise value:
161.1B
EV / Invested capital:
--
Price / LTM sales:
12.92x
EV / EBIT:
30.08x
EV / Revenue:
12.86x
PEG ratio (5yr expected):
0.84x
EV / Free cash flow:
41.59x
Price / Operating cash flow:
41.76x
Enterprise value / EBITDA:
28.01x
Gross Profit (TTM):
$7.6B
Return On Assets:
27.07%
Net Income Margin (TTM):
33.84%
Return On Equity:
101.72%
Return On Invested Capital:
40.75%
Operating Margin:
41.32%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $10.1B $10.2B $12.5B $2.8B $3.2B
Gross Profit $6B $6.2B $7.6B $1.7B $1.9B
Operating Income $3.9B $4.1B $5.4B $1.2B $1.3B
EBITDA $4.3B $4.5B $5.7B $1.3B $1.4B
Diluted EPS $22.31 $21.90 $31.85 $7.01 $8.47
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $6.1B $7.5B $8.3B $10B $10.7B
Total Assets $11.1B $13.1B $14.1B $15.7B $16.3B
Current Liabilities $2.5B $3.1B $3.8B $4.8B $4B
Total Liabilities $7.3B $11B $11.1B $12.1B $11.3B
Total Equity $3.9B $2.1B $3B $3.6B $5B
Total Debt $3.5B $6.4B $6B $6.8B $6B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $3.5B $3.4B $4.2B $995.2M $1.2B
Cash From Investing -$820.8M -$1.3B -$441.4M -$171M -$410M
Cash From Financing -$2.8B -$1.9B -$3.8B -$837.7M -$881.8M
Free Cash Flow $3.2B $3.2B $3.9B $934.8M $1.1B
KLAC
Sector
Market Cap
$159.7B
$51.5M
Price % of 52-Week High
94.43%
57.84%
Dividend Yield
0.61%
0%
Shareholder Yield
2.16%
--
1-Year Price Total Return
92.83%
-15.08%
Beta (5-Year)
1.447
0.657
Dividend yield:
0.61%
Annualized payout:
$6.75
Payout ratio:
22.44%
Growth streak:
9 years

Technicals

8-day SMA
Sell
Level $1,256.97
200-day SMA
Buy
Level $942.39
Bollinger Bands (100)
Buy
Level 963.36 - 1220.32
Chaikin Money Flow
Buy
Level 453.2M
20-day SMA
Sell
Level $1,233.11
Relative Strength Index (RSI14)
Sell
Level 49.23
ADX Line
Sell
Level 12.63
Williams %R
Neutral
Level -61.0884
50-day SMA
Buy
Level $1,197.53
MACD (12, 26)
Buy
Level 19.96
25-day Aroon Oscillator
Buy
Level 84
On Balance Volume
Neutral
Level 412.8M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (8.6897)
Buy
CA Score (Annual)
Level (0.1509)
Buy
Beneish M-Score (Annual)
Level (-2.2227)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.3468)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (10)

Revenue Forecast

Earnings per Share Forecast

Company Profile

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

Stock Forecast FAQ

In the current month, KLAC has received 10 Buy ratings 14 Hold ratings, and 0 Sell ratings. The KLAC average analyst price target in the past 3 months is $1,320.96.

  • Where Will KLA Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that KLA Corp. share price will rise to $1,320.96 per share over the next 12 months.

  • What Do Analysts Say About KLA Corp.?

    Analysts are divided on their view about KLA Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that KLA Corp. is a Sell and believe this share price will drop from its current level to $1,000.00.

  • What Is KLA Corp.'s Price Target?

    The price target for KLA Corp. over the next 1-year time period is forecast to be $1,320.96 according to 24 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 14 analysts rate the stock a Hold.

  • Is KLAC A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for KLA Corp. is a Hold. 14 of 24 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of KLAC?

    You can purchase shares of KLA Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase KLA Corp. shares.

  • What Is The KLA Corp. Share Price Today?

    KLA Corp. was last trading at $1,215.40 per share. This represents the most recent stock quote for KLA Corp.. Yesterday, KLA Corp. closed at $1,215.08 per share.

  • How To Buy KLA Corp. Stock Online?

    In order to purchase KLA Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 1

Corcept Therapeutics, Inc. [CORT] is down 50.44% over the past day.

Buy
75
AXSM alert for Jan 1

Axsome Therapeutics, Inc. [AXSM] is up 22.82% over the past day.

Sell
50
NUTX alert for Jan 1

Nutex Health, Inc. [NUTX] is down 9.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock